Literature DB >> 33065087

Meta-Analysis Comparing the Frequency of Carotid Artery Stenosis in Patients With Atrial Fibrillation and Vice Versa.

Jean Jacques Noubiap1, Thomas A Agbaedeng2, Joel Noutakdie Tochie3, Jan René Nkeck4, Aude Laetitia Ndoadoumgue5, John L Fitzgerald6, Timothy Kleinig7, Gijo Thomas2, Melissa E Middeldorp6, Prashanthan Sanders6.   

Abstract

Atrial fibrillation (AF) and carotid stenosis (CS) can coexist and this association has been reported to result in a higher risk of stroke than attributed to either condition alone. Here we aimed to summarize the data on the association of CS and AF. MEDLINE and Embase were searched to identify all published studies providing relevant data through February 27, 2020. Random-effects meta-analysis method was used to pool estimates of prevalence. Heterogeneity was assessed by mean I-squared statistic. Forty-eight studies were included, 20 reporting on the prevalence of carotid disease in a pooled population of 49,070 AF patients, and 28 on the prevalence of AF in a total of 2,288,265 patients with carotid disease. The pooled prevalence of CS in AF patients was 12.4% (95% confidence interval [CI] 8.7 to 16.0, I2 93%; n = 3,919), ranging from 4.4% to 24.3%. The pooled prevalence of carotid plaque was 48.4% (95% CI 35.2 to 61.7, I2 = 99%; n = 4292). The prevalence of AF in patients with CS was 9.3% (95% CI 8.7 to 10.0, I2 99%; n = 2,286,518), ranging from 3.6% to 10.0%. This prevalence was much higher (p <0.001) in patients undergoing carotid artery stenting (12.7%, 95% CI 11.3 to 14.02, I2 38.3%) compared with those undergoing carotid endarterectomy (6.9%, 95% CI 8.3 to 10.4, I2 94.1%). There was no difference in AF prevalence between patients with CS, with and without previous cerebrovascular event (p >0.05). In conclusion, AF and CS frequently coexist, with about one in ten patients with AF having CS, and vice versa. In addition, nonstenotic carotid disease is present in about half of AF patients. These findings have important implications for AF screening in patients with CS, stroke prevention, and the opportunities to intervene on common risk factors.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 33065087     DOI: 10.1016/j.amjcard.2020.10.017

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

1.  Antithrombotic Treatment after Carotid Stenting in Patients with Concomitant Atrial Fibrillation.

Authors:  B Pardo-Galiana; M Medina-Rodriguez; M Millan-Vazquez; J A Cabezas-Rodriguez; L Lebrato-Hernandez; L Ainz-Gomez; E Zapata-Arriaza; J Ortega; A de Albóniga-Chindurza; J Montaner; A Gonzalez; F Moniche
Journal:  AJNR Am J Neuroradiol       Date:  2022-04-07       Impact factor: 3.825

2.  Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke.

Authors:  Gregory Y H Lip; Deirdre A Lane; Radosław Lenarczyk; Giuseppe Boriani; Wolfram Doehner; Laura A Benjamin; Marc Fisher; Deborah Lowe; Ralph L Sacco; Renate Schnabel; Caroline Watkins; George Ntaios; Tatjana Potpara
Journal:  Eur Heart J       Date:  2022-07-07       Impact factor: 35.855

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.